--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
AVBP ArriVent BioPharma
- 26.720
- +0.840+3.25%
Close Dec 13 16:00 ET
- 26.720
- 0.0000.00%
Post 16:20 ET
900.39MMarket Cap-11.11P/E (TTM)
27.030High25.360Low148.28KVolume25.880Open25.880Pre Close3.93MTurnover0.94%Turnover RatioLossP/E (Static)33.70MShares36.37052wk High3.24P/B423.83MFloat Cap14.35052wk Low--Dividend TTM15.86MShs Float36.370Historical High--Div YieldTTM6.45%Amplitude14.350Historical Low26.536Avg Price1Lot Size
ArriVent BioPharma Key Stats
ArriVent BioPharma Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
ArriVent BioPharma Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data